Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06134154 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Carbon Dioxide Gas for Endoscopy
A NA study of Abdominal Pain, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT06134154: Recruiting NA study of Abdominal Pain, sponsored by University of Alabama at Birmingham.
NCT06134154 is a NA study of Abdominal Pain that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 350 participants, above the 132-participant average among 19 other Abdominal Pain trials with a reported enrollment target (165% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06134154, a NA study of Abdominal Pain, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the efficacy and safety of air versus carbon dioxide gas insufflation for endoscopy in children. The main question\[s\] it aims to answer are: •to determine safety of CO2 Assess patient comfort (abdominal pain, flatulence and bloating) with CO2 use when compared to air.
Primary Outcome
Rates of abdominal pain from pre-procedure to immediately after the procedure
Conditions Studied
Interventions
- OTHER Endoscopic insufflation gas
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06134154 shows while recruiting
NCT06134154 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 132-participant average among 19 other Abdominal Pain trials with a reported enrollment target (165% higher).
The record links to 1 condition, with Abdominal Pain appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic insufflation gas is the first listed.
NCT06134154 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06134154 about?
NCT06134154 is a clinical study titled "Safety and Efficacy of Carbon Dioxide Gas for Endoscopy". The goal of this clinical trial is to compare the efficacy and safety of air versus carbon dioxide gas insufflation for endoscopy in children. The main question\[s\] it aims to answer are: •to determine safety of CO2 Assess patient comfort (abdominal pain, flatulence and bloating) with CO2 use whe...
What is the current status of trial NCT06134154?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-01-24. Estimated completion is 2028-12.
What conditions does trial NCT06134154 study?
This clinical trial studies the following conditions: Abdominal Pain.
What interventions are being tested in trial NCT06134154?
The interventions under investigation include: Endoscopic insufflation gas (OTHER).
Who is sponsoring clinical trial NCT06134154?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06134154 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06134154's enrollment target sits among peer trials
350 2nd of 19 the highest of 19 other Abdominal Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abdominal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
GI Alpha-Gal Study
RECRUITING · NA
-
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
RECRUITING · NA
-
Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children
RECRUITING · NA
-
Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain
RECRUITING · NA
-
Problem Solving Skills Training For Parent Caregivers of Youth With Chronic Pain
COMPLETED · NA
-
POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI